Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
44.25
-0.83 (-1.84%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Enliven Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $65 → $73 | Buy | Maintains | $65 → $73 | +64.97% | Oct 19, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 8, 2026 |
| Barclays | Barclays | Buy Maintains $78 | Buy | Maintains | $78 | +76.27% | Oct 7, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $70 | Buy | Initiates | $70 | +58.19% | Oct 5, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $75 | Buy | Initiates | $75 | +69.49% | Oct 1, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $62 → $73 | Buy | Maintains | $62 → $73 | +64.97% | Aug 17, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $82 | Buy | Reiterates | $82 | +85.31% | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.